AutoGenomics officially withdraws $60 million IPO

By
A A A

AutoGenomics, which provides a molecular diagnostics system for genetic testing in clinical laboratories, withdrew its plans for an initial public offering on Friday citing poor market conditions. The Vista, CA-based company was founded in 1999 and had previously announced in February its plans to pull its IPO. Leerink Swann was set to be the joint bookrunner on the deal.




The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.




This article appears in: News Headlines , IPOs

Referenced Stocks: AGMX

Renaissance Capital

Renaissance Capital

More from Renaissance Capital:

Related Videos

Freshman Finance 101
Freshman Finance 101                
Spot the Dropout RRC
Spot the Dropout RRC                
Power on/Power Off
Power on/Power Off                  

Stocks

Referenced

Most Active by Volume

63,683,265
  • $16.34 ▼ 0.12%
57,325,180
  • $10.64 ▲ 1.33%
54,257,396
  • $112.76 ▼ 0.47%
40,860,148
  • $5.86 ▲ 1.38%
40,102,780
  • $28.54 ▲ 0.42%
36,273,767
  • $104.31 ▼ 1.24%
36,196,207
  • $13.87 ▲ 0.95%
35,675,931
  • $10.40 ▲ 0.97%
As of 8/31/2015, 04:15 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com